EPIVIR
NDC 49702-204, lamivudine, tablet, film coated, from ViiV Healthcare Company.
- Product NDC
- 49702-204
- Status
- Listed
- Labeler
- ViiV Healthcare Company
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020564
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49702-204 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMIVUDINE300 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49702-204-13 | 49702020413 | 30 TABLET, FILM COATED in 1 BOTTLE (49702-204-13) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/89226149-47fa-4f7d-bb1f-1aa7034486b8
Use it
Look up 49702-204 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49702-204 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49702-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.